Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Linoleic Acid (C18:2(9Z,12Z)): Technical Guidance for Lab Us

    2026-06-25

    Linoleic Acid (C18:2(9Z,12Z)): Technical Guidance for Lab Use

    What This Product Solves

    Linoleic Acid, supplied as an oily liquid (CAS No.: 60-33-3, C18H32O2), is an essential omega-6 fatty acid widely applied in cellular and animal research to model oxidative stress, membrane dynamics, and essential fatty acid deficiency. Its integration into membrane phospholipids impacts membrane fluidity and barrier function, making it valuable for workflows focused on erythrocyte deformation assays, oxidative stress assays, and cell migration assays. The compound is particularly suited for investigations into lipid signaling and redox processes, including the study of lipid peroxidation and antioxidant enzyme interactions. For researchers modeling nutritional deficiency, Linoleic Acid provides a practical tool to manipulate and monitor essential fatty acid status in vitro and in vivo. It is not appropriate for protocols requiring water-soluble reagents or for workflows operating with stock solutions stored over extended periods. For complete product specifications, refer to the Linoleic Acid page.

    Protocol Parameters

    • Oxidative stress assay | 10–100 µM | Cell-based, animal, or erythrocyte models | Concentration range aligns with redox modulation and lipid peroxidation studies as described in the product dossier; supports reliable induction of oxidative stress and hemolytic damage. | product-spec
    • Solvent compatibility | Soluble in ethanol (≥29 mg/mL) and DMSO (≥31.6 mg/mL); insoluble in water | All in vitro and in vivo applications requiring homogeneous solutions | Solvent choice is dictated by product solubility data; enables accurate dosing and prevents precipitation artifacts. | product-spec
    • Stock solution storage | Freshly prepared solutions recommended; long-term storage not advised | Any protocol using Linoleic Acid solutions | Oxidative lability and loss of function occur with extended storage, so stocks should be made immediately prior to use to maintain experimental integrity. | product-spec
    • Cell migration assay | Micromolar concentrations (e.g., 1–50 µM) | In vitro epithelial cell migration/barrier function research | Product dossier reports modulation of cell migration at these doses, supporting use in wound healing and barrier assays. | product-spec
    • Animal model nutritional deficiency | Dietary supplementation or depletion protocols | Rodent or other animal models | Use as a defined essential fatty acid source or to model deficiency states in vivo. | workflow recommendation

    Workflow Setup and QC Checklist

    • Use only ethanol or DMSO as solvents for Linoleic Acid; confirm full dissolution before dilution into culture media or vehicle.
    • Prepare stock solutions immediately prior to experiment; avoid freeze-thaw cycles and prolonged storage, as per product guidance.
    • When diluting into aqueous systems, pre-warm solvents and vortex thoroughly to avoid precipitation.
    • Include negative (vehicle-only) and positive (oxidative challenge) controls in oxidative stress and erythrocyte deformation assays to validate response specificity.
    • Monitor pH and osmolarity in cell-based assays following Linoleic Acid addition, as solvent carryover may affect these parameters.
    • Document solvent concentration in all working solutions; ensure final DMSO or ethanol content does not exceed cytotoxicity thresholds for the chosen cell line or animal model.

    For additional technical workflow standards, see Linoleic Acid (C18:2(9Z,12Z)): Technical Use and Workflow Standards, which details validated handling and assay integration.

    Common Failure Modes and Fixes

    • Precipitation in aqueous media: Linoleic Acid is insoluble in water. To prevent precipitation, always first dissolve in ethanol or DMSO at the recommended concentration, then dilute into media under vigorous mixing. Do not exceed the solubility limit of the solvent.
    • Loss of activity upon storage: The compound is susceptible to oxidative degradation. Prepare stocks fresh, store at -20°C only for short durations, and minimize freeze-thaw cycles. Discard any solutions exhibiting discoloration or phase separation.
    • Inconsistent assay results: Document the exact solvent and concentration used in each experiment. Standardize the time interval between solution preparation and usage. Confirm that solvent carryover is below cytotoxic thresholds in all control and treatment wells.
    • Cytotoxicity from solvent: Ensure final DMSO or ethanol concentrations are compatible with the biological system. Include solvent-only controls to distinguish Linoleic Acid effects from solvent artifacts.

    Further practical troubleshooting for membrane fluidity and redox modeling can be found in Linoleic Acid (C18:2(9Z,12Z)): Technical Use and Workflow Guide, which covers common challenges and setup errors.

    Scope and Limitations

    • Linoleic Acid is optimized for modeling oxidative stress, membrane dynamics, and essential fatty acid deficiency in cell-based and animal workflows, including oxidative stress and cell migration assays.
    • It is unsuitable for protocols requiring aqueous solubility; direct addition to water-based systems without prior solvent dissolution will lead to precipitation and unreliable dosing.
    • Long-term stock solution storage is not advised; all working solutions should be freshly prepared to preserve reagent integrity and experimental reproducibility.
    • Not recommended for use in protocols that do not allow for the use of organic solvents (ethanol or DMSO) or that require extended reagent stability at room temperature.
    • All concentrations and workflows should be validated in pilot runs for the specific cell type or animal model; generic dosage extrapolation may not capture system-specific sensitivities.
    • Mechanistic claims beyond the direct modulation of redox balance, lipid peroxidation, and membrane fluidity should be avoided unless supported by additional evidence.

    Conclusion

    Linoleic Acid (C18:2(9Z,12Z), SKU C3108) is a validated, practical tool for researchers investigating membrane properties, redox biology, and nutritional deficiency in cellular and animal models. Adhering to solvent compatibility, fresh solution preparation, and rigorous QC minimizes variability and supports robust, reproducible outcomes. For detailed specifications and ordering, visit the APExBIO Linoleic Acid product page. Reference to internal technical articles is recommended for detailed troubleshooting and workflow optimization.